Follow Us
https://www.thebody.com/category/viread-tenofovir-tdf
HIV Treatment and Medical Care

Viread (Tenofovir Disoproxil Fumarate)

The Latest

An Overview of Viread (Tenofovir) Img

An Overview of Viread (Tenofovir)

Brand Name: Viread Other Names: TDF, tenofovir DF Drug Class: Nucleoside Reverse Transcriptase Inhibitors

With the Public Attuned to Drug Pricing, Advocates Request Affordable Rate for New HIV Drug Img
News

With the Public Attuned to Drug Pricing, Advocates Request Affordable Rate for New HIV Drug

The Fair Pricing Coalition says that patients, insurers and public programs shouldn't have to pay higher costs for a next-generation HIV treatment could make combination therapy less toxic.

Promo Image

Viread

Brand name: Viread

Generic name: tenofovir disoproxil fumarate (tenofovir), or TDF

Class: Nucleotide reverse transcriptase inhibitor(nucleotide, NtRTI, or nuke)

Manufacturer: Gilead Sciences, Inc., www.Viread.com, (800) GILEAD-5 (445-3235)

AWP: $...

Promo Image

Tenofovir (Viread)

What Is Tenofovir? Who Should Take Tenofovir? What About Drug Resistance? How Is Tenofovir Taken? What Are the Side Effects? How Does Tenofovir React With Other Drugs?

What Is Tenofovir?

Tenofovir (Viread), also called bis-POC PMPA, is ...

Promo Image

Viread (Tenofovir)

Viread is supplied in 300-mg tablets that are almond shaped, light blue film coated, and embossed with "GILEAD" and "4331" on one side and with "300" on the other side.

Background Coformulations Dose Food Restrictions Storage Patient Assis...

Promo Image
News

Gilead Sciences First-Quarter Profits Driven by Increase in Sales of Antiretroviral Viread

Foster City, Calif.-based Gilead Sciences on Thursday announced first-quarter 2004 net profits of $114.4 million, up from a net loss of $438.1 million during the same quarter last year, an increase largely driven by sales of its antiretroviral drug V...

Promo Image
News

Atazanavir (Reyataz): New Recommendations if Combined With Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra

On March 19, 2004 the FDA notified the public of new prescribing information and precautions for atazanavir (brand name Reyataz), if taken in combination with tenofovir (Viread) -- and warned of risks with Viagra or similar drugs.

If atazanavir is t...

Promo Image
News

U.S. Approves Emtriva; Gilead Hopes Viread/Emtriva Combo Will Compete With Combivir

Gilead Sciences received approval from the US Food and Drug Administration Wednesday for a new once-a-day AIDS drug, Emtriva. Known generically as emtricitabine, Emtriva is a nucleoside reverse transcriptase inhibitor. Gilead now hopes to combine Emt...

Promo Image
News

Tenofovir DF on the Horizon

A new drug application for Tenofovir disoproxil fumarate (Tenofovir DF) has been filed with the Food and Drug Administration by Gilead Sciences. Tenofovir DF, also known as PMPA, could be approved within the next six months.

Tenofovir DF is an inves...

Promo Image
News

Tenofovir: FDA Hearing October 3, Public Comment Deadlines September 26

On October 3 the FDA's Antiviral Drugs Advisory Committee will hold a public hearing on tenofovir (full chemical name tenofovir disoproxil fumarate, or tenofovir DF; new brand name Viread™, an antiretroviral developed by Gilead Sciences and currently...